Alerte De Sécurité sur ELS SYRINGE FOR ANGIOGRAPHY GUERBET - Model: 00 000 000 3160 25, Registro ANVISA: 10061400027

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par MEDTRON AG.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    1354
  • Date
    2014-02-06
  • Pays de l'événement
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    Blue particles from the protective caps of the syringes may eventually come loose into the syringes. This occurs due to friction in the material when the protective cap is threaded during the syringe manufacturing process. The friction can cause wear and consequently, the particle generated in this friction can fall into the syringe. The cause identified for this quality deviation was a tool modification by the manufacturer of the product. The consequences may range from local redness to involvement of the microcirculation with blood vessel obstruction and phlebitis, as well as possible damage to organs such as the lungs, liver, kidneys and spleen due to the formation of granulomas. According to the registry holder in Brazil, no incident notification has been received so far. The actions have already been taken by the manufacturer and the problem has been eliminated in production. In order to avoid any risk to patients, the involved lots will be collected and destroyed.
  • Cause
    It has been shown that blue particles from the protective caps of the syringes may eventually fall into the syringes.
  • Action
    Gathering and destruction

Manufacturer